Guangxin Ma

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A Tertiary Lymphoid Structure-Derived Prognostic Signature Integrates Immune Microenvironment and Mutational Landscapes in Clear Cell Renal Cell Carcinoma.

A Tertiary Lymphoid Structure-Derived Prognostic Signature Integrates Immune Microenvironment and Mutational Landscapes in Clear Cell Renal Cell Carcinoma.

Journal: Human mutation

Published: January 21, 2026

Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma.

Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma.

Journal: Scientific reports

Published: January 15, 2024

Development of macrophage-associated genes prognostic signature predicts clinical outcome and immune infiltration for sepsis.

Development of macrophage-associated genes prognostic signature predicts clinical outcome and immune infiltration for sepsis.

Journal: Scientific reports

Published: October 06, 2023

Prognostic Value of PIK3R4 Expression and Its Correlation with Immune Cell Infiltration in the Diffuse Large B-cell Lymphoma Microenvironment.

Prognostic Value of PIK3R4 Expression and Its Correlation with Immune Cell Infiltration in the Diffuse Large B-cell Lymphoma Microenvironment.

Journal: Journal of Cancer

Published: May 31, 2023

Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma.

Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma.

Journal: Aging

Published: May 06, 2023

An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer.

An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer.

Journal: Aging

Published: March 01, 2023

A Novel Fatty Acid Metabolism-Associated Risk Model for Prognosis Prediction in Acute Myeloid Leukaemia.

A Novel Fatty Acid Metabolism-Associated Risk Model for Prognosis Prediction in Acute Myeloid Leukaemia.

Journal: Current oncology (Toronto, Ont.)

Published: December 26, 2022

Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma.

Significance of immunogenic cell death-related genes in prognosis prediction and immune microenvironment landscape of patients with cutaneous melanoma.

Journal: Frontiers in genetics

Published: July 07, 2022

The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia.

The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia.

Journal: Frontiers in cell and developmental biology

Published: June 26, 2022

Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia.

Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia.

Journal: BMC cancer

Published: October 15, 2021

Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients.

Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients.

Journal: Frontiers in genetics

Published: September 26, 2021

LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia.

LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophilia.

Journal: Molecular carcinogenesis

Published: July 22, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026